Page last updated: 2024-10-20

putrescine and Arterial Occlusive Diseases

putrescine has been researched along with Arterial Occlusive Diseases in 3 studies

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"The possible effects of the polyamine interconversion pathway on tissue polyamine levels, brain edema formation, and ischemic injury volume were studied by using a selective irreversible inhibitor, MDL 72527, of the interconversion pathway enzyme, polyamine oxidase."7.70Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion. ( Başkaya, MK; Dempsey, RJ; Doğan, A; Hatcher, J; Rao, AM; Rao, VL, 1999)
"The possible effects of the polyamine interconversion pathway on tissue polyamine levels, brain edema formation, and ischemic injury volume were studied by using a selective irreversible inhibitor, MDL 72527, of the interconversion pathway enzyme, polyamine oxidase."3.70Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion. ( Başkaya, MK; Dempsey, RJ; Doğan, A; Hatcher, J; Rao, AM; Rao, VL, 1999)
"Cerebral ischemia causes activation of ornithine decarboxylase (ODC) gene and subsequent accumulation of putrescine, which might either directly or indirectly affect the outcome of cerebral infarct."3.69Transgenic rats as models for studying the role of ornithine decarboxylase expression in permanent middle cerebral artery occlusion. ( Alhonen, LI; Gröhn, OH; Jänne, J; Järvinen, A; Kauppinen, RA; Lukkarinen, J; Sinervirta, R, 1997)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lukkarinen, J1
Gröhn, OH1
Sinervirta, R1
Järvinen, A1
Kauppinen, RA1
Jänne, J1
Alhonen, LI1
Doğan, A2
Rao, AM2
Hatcher, J1
Rao, VL1
Başkaya, MK1
Dempsey, RJ2
Hatcher, JF1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase II Study of the Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage[NCT01095731]Phase 260 participants (Actual)Interventional2010-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for putrescine and Arterial Occlusive Diseases

ArticleYear
Transgenic rats as models for studying the role of ornithine decarboxylase expression in permanent middle cerebral artery occlusion.
    Stroke, 1997, Volume: 28, Issue:3

    Topics: Animals; Animals, Genetically Modified; Arterial Occlusive Diseases; Brain Ischemia; Cell Death; Dis

1997
Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion.
    Journal of neurochemistry, 1999, Volume: 72, Issue:2

    Topics: Animals; Arterial Occlusive Diseases; Blood Gas Analysis; Blood Pressure; Body Temperature; Brain; B

1999
Elevated N1-acetylspermidine levels in gerbil and rat brains after CNS injury.
    Journal of neurochemistry, 2000, Volume: 74, Issue:3

    Topics: Animals; Arterial Occlusive Diseases; Blood-Brain Barrier; Brain; Brain Injuries; Cerebral Arteries;

2000